3 Medical Instrument Stocks Banking on GenAI to Tackle Industry Woes

ISRG, EW and ELMD tap GenAI to enhance diagnostics and workflows, even as MedTech faces cost pressures, data risks and macro headwinds.

Zacks Investment Research • Feb 23, 2026

Edwards Lifesciences to Present at the Barclays and Leerink Partners Global Healthcare Conferences

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced its chief financial officer, Scott Ullem, is scheduled to present at two upcoming conferences: Tuesday, March 10, 2026 at 10:00 a.m. ET at the Barclays 28th Annual Global Healthcare Conference Wednesday, March 11, 2026 at 10:00 a.m. ET at the Leerink Global Healthcare Conference A live webcast of each presentation will be available on the Edwards investor relations website at http://ir.edwards.com/, wit.

Business Wire • Feb 19, 2026

Edwards Lifesciences scraps anti-copycat policy, EU drops antitrust investigation

U.S. medical device maker Edwards Lifesciences has scrapped its anti-copycat policy that triggered a complaint from an Indian rival, EU antitrust regulators said on Monday as they closed their investigation into the company.

Reuters • Feb 16, 2026

Edwards Lifesciences to Present at Citi's 2026 Unplugged Medtech and Life Sciences Access Day

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in Citi's Unplugged Medtech and Life Sciences Access Day on February 26, 2026. Scott Ullem, chief financial officer, is scheduled to present at 10:15 a.m. ET. A live webcast of the presentation will be available on the Edwards Lifesciences investor relations website at http://ir.edwards.com/, with an archived version accessible later the same day. About Edwards Lifesciences Edwards L.

Business Wire • Feb 13, 2026

Halper Sadeh LLC Encourages Edwards Lifesciences Corporation Shareholders to Contact the Firm to Discuss Their Rights

Shareholders should contact the firm immediately as there may be limited time to enforce your rights. Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

GlobeNewsWire • Feb 12, 2026

A Closer Look at Healthcare Sector Earnings: AZN vs. EW vs. ZBH

More than just a financial check-up, earnings for companies in the healthcare sector offer a key window for investors into a firm's pipeline and development progress. Even well-established, stable firms in the healthcare space can surprise with growth upon the release of a new blockbuster drug or medical device, and earnings periods are an opportunity for management to provide insight and commentary beyond what investors might expect from FDA notices of approvals, for example.

MarketBeat • Feb 12, 2026

EW's Q4 Earnings Miss Estimates, Revenues Up Y/Y, Stock Climbs

Edwards' Q4 EPS lags estimates but revenues top as TAVR and TMTT surge. Shares rise with 2026 sales growth seen at 8%-10%.

Zacks Investment Research • Feb 11, 2026

Edwards Lifesciences forecasts 2026 profit above estimates on heart devices strength

Edwards Lifesciences on Tuesday forecast 2026 profit above estimates, betting on robust demand for its artificial heart valves and other medical devices, sending its shares up 3% in after-hours trading.

Reuters • Feb 10, 2026

Edwards Lifesciences Pops On Its Bullish 2026 View Despite Mixed Fourth Quarter

Edwards Lifesciences stock rose late Tuesday after earnings missed forecasts but fourth-quarter sales beat.

Investors Business Daily • Feb 10, 2026

Edwards Lifesciences Corporation (EW) Q4 2025 Earnings Call Transcript

Edwards Lifesciences Corporation (EW) Q4 2025 Earnings Call Transcript

Seeking Alpha • Feb 11, 2026